Testosterone Undecanoate Oral Dosage: Complete TRT Guide

The following blog post is for entertainment and informational purposes only. It is not intended to provide medical advice or diagnosis. Please consult your doctor before making any health-related decisions.

Testosterone undecanoate oral dosage is not a universal starting point. A licensed provider determines the right dose after reviewing baseline lab values, symptom history, and individual metabolic factors. Kyzatrex oral testosterone is the oral testosterone undecanoate formulation available to manage hypogonadism in the US, and prescribing follows a structured titration process built around each patient's response. Knowing what shapes that process helps you ask better questions before your first clinical appointment.

What makes oral testosterone undecanoate different

Oral testosterone undecanoate bypasses first-pass liver metabolism by absorbing through the intestinal lymphatic system. That distinction is clinically significant. It explains why every dose must be taken with a fat-containing meal. Without dietary fat, absorption drops substantially. The compound then converts in the body to biologically active testosterone, and its shorter half-life in oral form means oral testosterone therapy requires more consistent daily administration than long-acting injectable esters.

A 2022 review by Wang et al. in Endocrinology and Metabolism Clinics of North America confirmed that oral testosterone undecanoate can restore testosterone to the physiological range in hypogonadal men, with response closely tied to consistent meal-timed dosing.

How oral testosterone undecanoate compares to injectable TRT:

Feature	Oral testosterone undecanoate	Injectable TRT
Administration	Oral capsule with fat-containing meal	Intramuscular or subcutaneous injection
Liver exposure	Minimal (lymphatic route)	Not first-pass metabolized
Dose interval	Daily, in divided doses	Weekly to quarterly depending on ester
Bioavailability factor	Fat content of the meal	Injection technique and site
Dose set by	Provider after lab review	Provider after lab review

For a practical look at how oral and injectable testosterone routes compare, including tradeoffs in level stability and protocol adherence, the differences go deeper than delivery method alone.

What is the recommended oral testosterone undecanoate dosage for TRT?

A licensed provider determines the testosterone undecanoate oral dosage individually. There is no universal starting number that applies across patients. Baseline serum testosterone, symptom severity, body composition, age, and concurrent health conditions all factor into the initial prescription. The target of titration is to restore testosterone to the mid-normal physiological range, assessed through follow-up labs at approximately six to eight weeks.

Khera et al. (2025), writing in Sexual Medicine Reviews, note that practical guidance on testosterone therapy must account for significant individual variability in drug response. Provider-guided titration, not patient-selected dosing, is the standard that reduces both under- and over-replacement.

If follow-up labs show testosterone below the target range and symptoms persist, the dose may be adjusted upward. If levels run above range, the provider reduces or modifies timing. Getting to a stable testosterone undecanoate dose typically takes two to three titration cycles. That back-and-forth is a normal part of any oral TRT protocol.

How often should you take oral testosterone undecanoate?

Oral testosterone undecanoate has a shorter half-life than injectable forms. TRT dosing frequency for this compound is therefore daily, with doses taken in divided intervals across the day to maintain more stable serum levels. Building a structured oral testosterone cycle requires consistent timing and meal composition, not just the right dose amount.

Skipping doses or taking capsules without adequate dietary fat both reduce circulating testosterone meaningfully. The schedule is set by the prescribing provider. Patients should not modify it without first retesting to confirm where their levels actually sit.

What is the standard Kyzatrex dosage for men?

Kyzatrex is the brand name for oral testosterone undecanoate used to manage confirmed hypogonadism in men. For Kyzatrex dosage men, a provider sets the initial prescription after a formal hypogonadism diagnosis, which requires at least two morning testosterone measurements below the normal range alongside documented symptoms.

Khera et al. (2025) emphasize that confirming hypogonadism before prescribing is not optional. It is a clinical requirement. Without confirmation, therapy may be initiated in men with transient low levels from illness, poor sleep, or acute stress, none of which represent true hypogonadism.

After initiation, follow-up labs guide titration. If testosterone does not reach the mid-normal range, the dose is increased. If levels overshoot, the provider reduces. Kyzatrex must be taken with a fat-containing meal at every dose because intestinal lymphatic transport is fat-activated. A low-fat or skipped meal meaningfully reduces bioavailability.

Factors that shape an oral TRT protocol

Several clinical variables directly affect the testosterone undecanoate oral dosage a provider chooses. Understanding each one helps explain why two men with the same lab result can end up on different protocols.

Age and testosterone trajectory

Testosterone production declines with age. Older men typically require closer monitoring during titration because baseline levels are lower and comorbidities are more common. Younger men with confirmed hypogonadism may metabolize the compound differently under an equivalent dose.

Weight and body composition

Higher body weight correlates with a larger distribution volume. A person with significantly greater lean mass or overall weight may reach a lower serum concentration at a given dose than someone lighter. Providers account for this before setting the initial range.

Baseline testosterone and symptom burden

Pre-treatment labs establish the clinical reference point, but symptom severity matters just as much. Fatigue, reduced libido, difficulty concentrating, and mood changes each factor into the decision. Low testosterone on labs combined with significant symptoms supports initiation of oral testosterone therapy. Either factor alone shifts the clinical calculus.

Medical history and comorbidities

Conditions including liver dysfunction, cardiovascular disease, and polycythemia affect both safety and dosing. Wang et al. (2022) flag cardiovascular risk in men with pre-existing disease as a monitoring priority throughout TRT. Hepatic impairment can alter drug metabolism even via the lymphatic absorption route, prompting more frequent lab review.

Concomitant medications

Anticonvulsants can increase the metabolic clearance of testosterone, pulling therapeutic levels below target. Some antifungal agents inhibit CYP enzymes and may push testosterone above the intended range. A provider reviews the full medication list before prescribing and revisits it when patients add new drugs.

Lifestyle factors

Diet composition, alcohol use, exercise habits, and sleep quality all influence testosterone metabolism. Oral TRT protocol outcomes reflect more than the capsule alone. Providers often recommend lifestyle adjustments alongside pharmacotherapy to improve response and reduce adverse effects.

Can women use testosterone undecanoate orally?

Women can receive oral testosterone therapy in specific clinical contexts, but this is off-label use. Testosterone undecanoate is approved only for male hypogonadism. A 2016 review by Norjavaara et al. in Endocrine Development found that dosing regimens for sex steroid replacement must differ substantially between sexes. Female patients typically require much lower doses, and the risk profile differs as well.

The primary safety concern is virilization: voice deepening, clitoral enlargement, and abnormal hair growth. Any sign of virilization prompts reassessment of the dose or discontinuation of treatment. Women receiving testosterone undecanoate need more frequent follow-up labs than male patients throughout the course of therapy.

What are the side effects of oral testosterone undecanoate?

Oral testosterone therapy shares an adverse-effect profile with other TRT routes. Common side effects include:

• Acne and increased skin oiliness, most common in the first weeks of treatment
• Fluid retention, which may cause mild swelling in the lower extremities
• Mood changes, including irritability or emotional variability during dose titration
• Lipid profile shifts, potentially including reduced HDL and elevated LDL cholesterol

More serious effects require active monitoring. Polycythemia, an elevation in red blood cell count and hematocrit, is a recognized consequence of testosterone supplementation across all delivery routes. Providers check hematocrit at regular intervals and may adjust dose or recommend phlebotomy if levels climb into a concerning range.

Cardiovascular risk in men with pre-existing disease warrants direct discussion before starting any TRT route. Wang et al. (2022) note this as a core monitoring requirement throughout therapy.

For context on how route affects tolerability in oral versus injectable forms, side-effect profiles overlap substantially between the two delivery methods, with some route-specific differences in hematologic response and level stability.

Naelitz et al. (2025) in Nature Reviews Urology note that TRT in reproductive-age men suppresses spermatogenesis and can impair fertility. Men who want to preserve fertility should raise this explicitly with their provider before starting treatment.

Testosterone undecanoate bodybuilding: why clinical TRT is different

Some searches for testosterone undecanoate bodybuilding protocols reflect interest in using oral TU outside a medically supervised context. Clinical oral TRT targets restoration of physiological testosterone levels in men with confirmed deficiency. That goal is distinct from supraphysiological use. Valhalla Vitality reviews each case through a licensed provider who confirms whether therapy is appropriate before any prescription is written.

Using oral TU without a managed protocol removes the lab monitoring that catches polycythemia, cardiovascular changes, and lipid shifts before they become clinical problems. The risks of unsupervised use are real, and they are not offset by short-term performance goals.

Ready to discuss your options?

Book Your Consultation to connect with a licensed provider who can review your labs and determine whether a testosterone undecanoate oral dosage is appropriate for you.

FAQ

What is the recommended oral testosterone undecanoate dosage for TRT?

A licensed provider sets the dose individually based on lab results confirming hypogonadism. There is no universal starting number; the provider titrates upward or downward based on serum testosterone levels and symptom response at follow-up labs.

How often should you take oral testosterone undecanoate?

Oral testosterone undecanoate is taken in divided doses throughout the day, each with a fat-containing meal. The specific schedule is set by the prescribing provider and should not be modified without retesting to confirm current testosterone levels.

What is the standard Kyzatrex dosage for men?

Kyzatrex dosage for men is set individually after baseline labs confirm hypogonadism. Titration targets mid-normal testosterone levels, assessed at follow-up labs typically scheduled six to eight weeks after initiation.

Can women use testosterone undecanoate orally?

Women may receive oral testosterone undecanoate off-label for specific clinical indications, but it is not approved for female use. Doses are substantially lower than those prescribed to men, and monitoring for signs of virilization is required throughout treatment.

What are the side effects of oral testosterone undecanoate?

Common side effects include acne, fluid retention, mood changes, and lipid profile alterations. More serious effects such as elevated hematocrit and cardiovascular risk require regular lab monitoring and provider-guided dose adjustments throughout therapy.

Sources

1. Wang C et al. (2022). Testosterone Replacement Therapy in Hypogonadal Men. Endocrinology and Metabolism Clinics of North America. PubMed
2. Khera M et al. (2025). Testosterone deficiency and treatments: common misconceptions and practical guidance for patient care. Sexual Medicine Reviews. PubMed
3. Naelitz BD et al. (2025). Testosterone replacement therapy and spermatogenesis in reproductive age men. Nature Reviews Urology. PubMed
4. Norjavaara E et al. (2016). Sex Steroid Replacement Therapy in Female Hypogonadism from Childhood to Young Adulthood. Endocrine Development. PubMed